Alexander Ulrich Ernst

Alexander Ulrich Ernst

Auto-generated profile, based on publicly available information

Alexander Ulrich Ernst

Biological and Environmental Engineering, Cornell University, Ithaca, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
XWXi Wang
Xi Wang
KMKristina G. Maxwell
Kristina G. Maxwell
KWKai Wang
Kai Wang
DBDaniel T. Bowers
Daniel T. Bowers
JFJames A. Flanders
James A. Flanders
MMMinglin Ma
Minglin Ma
A nanofibrous cell encapsulation device containing rodent/human islets or human stem cell–derived β cells treats diabetes in rodents.

6 October 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
LWLong-Hai Wang
Long-Hai Wang
AEAlexander Ulrich Ernst
Alexander Ulrich Ernst
DADuo An
Duo An
ADAshim Kumar Datta
Ashim Kumar Datta
BEBoris Epel
Boris Epel
MMMinglin Ma
Minglin Ma
Inadequate oxygenation is a major challenge in cell encapsulation, a therapy which holds potential to treat many diseases including type I diabetes. In such systems, cellular oxygen (O2) delivery is limited to slow passive diffusion from transplantation sites through the poorly O2-soluble encapsulating matrix, usually a hydrogel. This constrains the maximum permitted distance between the encapsulated cells and host site to within a few hundred micrometers to ensure cellular function. Inspired by the natural gas-phase tracheal O2 delivery system of insects, we present herein the design of a biomimetic scaffold featuring internal continuous air channels endowed with 10,000-fold higher O2 diffusivity than hydrogels. We incorporate the scaffold into a bulk hydrogel containing cells, which facilitates rapid O2 transport through the whole system to cells several millimeters away from the device-host boundary. A computational model, validated by in vitro analysis, predicts that cells and islets maintain high viability even in a thick (6.6 mm) device. Finally, the therapeutic potential of the device is demonstrated through the correction of diabetes in immunocompetent mice using rat islets for over 6 months.

21 May 2019 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
AEAlexander U. Ernst
Alexander U. Ernst
LWLong‐Hai Wang
Long‐Hai Wang
MMMinglin Ma
Minglin Ma

5 December 2023 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
LWLong-Hai Wang
Long-Hai Wang
Braulio Marfil-GarzaBraulio Marfil-Garza
Braulio Marfil-Garza
AEAlexander U. Ernst
Alexander U. Ernst
RPRena L. Pawlick
Rena L. Pawlick
APAndrew R Pepper
Andrew R Pepper
ASAndrew Mark James Shapiro
Andrew Mark James Shapiro

13 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
AEAlexander U. Ernst
Alexander U. Ernst
LWLong-Hai Wang
Long-Hai Wang
SWScott C. Worland
Scott C. Worland
Braulio Marfil-GarzaBraulio Marfil-Garza
Braulio Marfil-Garza
XWXi Wang
Xi Wang
MMMinglin Ma
Minglin Ma
The delivery of encapsulated islets or stem cell-derived insulin-producing cells (i.e., bioartificial pancreas devices) may achieve a functional cure for type 1 diabetes, but their efficacy is limited by mass transport constraints. Modeling such constraints is thus desirable, but previous efforts invoke simplifications which limit the utility of their insights. Herein, we present a computational platform for investigating the therapeutic capacity of generic and user-programmable bioartificial pancreas devices, which accounts for highly influential stochastic properties including the size distribution and random localization of the cells. We first apply the platform in a study which finds that endogenous islet size distribution variance significantly influences device potency. Then we pursue optimizations, determining ideal device structures and estimates of the curative cell dose. Finally, we propose a new, device-specific islet equivalence conversion table, and develop a surrogate machine learning model, hosted on a web application, to rapidly produce these coefficients for user-defined devices.